Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. 144703-90-2
2. Type 11 Collagen
3. Mfcd32666130
4. Fc108481
5. Collagen Type Ii Fragment Trifluoroacetate Salt
| Molecular Weight | 2602.7 g/mol |
|---|---|
| Molecular Formula | C108H175F3N32O39 |
| Hydrogen Bond Donor Count | 35 |
| Hydrogen Bond Acceptor Count | 46 |
| Rotatable Bond Count | 79 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 1120 |
| Heavy Atom Count | 182 |
| Formal Charge | 0 |
| Complexity | 5790 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 21 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Details:
In a new partnership, Collagen Type II dietary supplement will target joint pain, aiming to improve overall joint health.
Lead Product(s): Collagen Type II,Inapplicable
Therapeutic Area: Musculoskeletal Brand Name: Undisclosed
Study Phase: Approved FDFProduct Type: Dietary Supplement
Sponsor: Stauber
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership February 11, 2025
Lead Product(s) : Collagen Type II,Inapplicable
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Stauber
Deal Size : Undisclosed
Deal Type : Partnership
Bioiberica Partners with STAUBER to Expand Distribution of Branded Ingredients in US
Details : In a new partnership, Collagen Type II dietary supplement will target joint pain, aiming to improve overall joint health.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Undisclosed
February 11, 2025
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Collagen Type II is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Osteoarthritis, Knee.
Lead Product(s): Collagen Type II,Dimethyl Sulfone,Boswellia Serrata,Vitamin D3,Ascorbic Acid
Therapeutic Area: Musculoskeletal Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Undisclosed
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable August 04, 2023

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Collagen Type II,Dimethyl Sulfone,Boswellia Serrata,Vitamin D3,Ascorbic Acid
Therapeutic Area : Musculoskeletal
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study of the Feasibility of Using the Dietary Supplement "ARTNEO" in Patients With Osteoathritis
Details : Collagen Type II is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Osteoarthritis, Knee.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 04, 2023

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Collagen Type II is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Arthralgia.
Lead Product(s): Collagen Type II,Inapplicable
Therapeutic Area: Musculoskeletal Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Undisclosed
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable January 28, 2022

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Collagen Type II,Inapplicable
Therapeutic Area : Musculoskeletal
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Clinical Study to Evaluate the Effect of Different Doses of UC-II® Supplementation on the Range...
Details : Collagen Type II is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Arthralgia.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
January 28, 2022

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
84
PharmaCompass offers a list of Collagen Type II API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Collagen Type II manufacturer or Collagen Type II supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Collagen Type II manufacturer or Collagen Type II supplier.
A Collagen Type II manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Collagen Type II, including repackagers and relabelers. The FDA regulates Collagen Type II manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Collagen Type II API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Collagen Type II supplier is an individual or a company that provides Collagen Type II active pharmaceutical ingredient (API) or Collagen Type II finished formulations upon request. The Collagen Type II suppliers may include Collagen Type II API manufacturers, exporters, distributors and traders.
Collagen Type II Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Collagen Type II GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Collagen Type II GMP manufacturer or Collagen Type II GMP API supplier for your needs.
A Collagen Type II CoA (Certificate of Analysis) is a formal document that attests to Collagen Type II's compliance with Collagen Type II specifications and serves as a tool for batch-level quality control.
Collagen Type II CoA mostly includes findings from lab analyses of a specific batch. For each Collagen Type II CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Collagen Type II may be tested according to a variety of international standards, such as European Pharmacopoeia (Collagen Type II EP), Collagen Type II JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Collagen Type II USP).